Asia Pacific Deep Brain Stimulation Devices Market Size

Asia Pacific Deep Brain Stimulation Devices Market Size 2025

Asia Pacific Deep Brain Stimulation Devices Market By Applications (Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications) By End User (Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others) By Country, Industry Analysis and Forecast, 2019 - 2025

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : April-2020 | Number of Pages : 76 | Format : PDF

COVID-19

Get in-depth analysis of the COVID-19 impact on the Asia Pacific Deep Brain Stimulation Devices Market

Market Report Description

The Asia Pacific Deep Brain Stimulation Devices Market would witness market growth of 17.6% CAGR during the forecast period (2019-2025). Asia Pacific is projected to see the fastest market growth due to the growing demand in countries like Japan, China and India. The rising disposable income leading to higher spending on healthcare would also support growth in the region. In addition, increasing awareness of various neurological disorders such as epilepsy, critical tremors and Parkinson's disease would fuel Asia Pacific's demand for DBS. Another major factor driving growth in the area is the growing number of medical settings such as specialty clinics and multispecialty hospitals.

During the past 4 decades the field of stereotactic and functional neurosurgery and DBS has expanded rapidly. With advancements in high-resolution imaging, including tractography and functional MRI, identification of individual nuclei or tracts has become more accurate. Such technological advancements also provide guidelines for intraoperative imaging and confirmation of the targets. Technological developments have also been made inside the unit. For standard PD patients the internal pulse generators (IPGs) have a battery life of about 4 years.

Additionally, there are transcutaneous, rechargeable IPGs. With advancements in stimulation programming, multiple options are critical to be able to provide. Today, there's the potential to provide stimulus paradigms interleaving. Modern IPGs can now provide programmed stimulation paradigms as well as store data from leads themselves collected from the electrode. Implanted monitoring systems have opened the way for more neurological disease studies and the underlying electrophysiological changes that arise in these states.

Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into China, India, Japan, Australia, South Korea, Singapore, and Rest of Asia Pacific.

Free Valuable Insights: Deep Brain Stimulation Devices Market in Asia Pacific is expected to register a CAGR of 17.6% during the forecast period (2019-2025)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.

Scope of the Asia Pacific Deep Brain Stimulation Devices Market Analysis

Market Segmentation:

By Applications

  • Parkinson's disease
  • Epilepsy
  • Essential Tremor
  • Dystonia
  • Obsessive Compulsive Disorder
  • Other Applications

By End User

  • Neurological Clinics
  • Ambulatory Surgical Centers
  • Hospital
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific

Companies Profiled

  • Abbott Laboratories
  • Medtronic PLC
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • Functional Neuromodulation, Ltd.
  • Beijing PINS Medical Co., Ltd.
  • NeuroPace, Inc.
  • Nevro Corporation
  • Neuronetics, Inc.
  • Fisher Wallace Laboratories, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Deep Brain Stimulation Devices Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities